IBDEI1ST ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,28718,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28718,1,3,0)
 ;;=3^Illness Anxiety D/O
 ;;^UTILITY(U,$J,358.3,28718,1,4,0)
 ;;=4^F45.21
 ;;^UTILITY(U,$J,358.3,28718,2)
 ;;=^5003587
 ;;^UTILITY(U,$J,358.3,28719,0)
 ;;=F68.A^^115^1415^6
 ;;^UTILITY(U,$J,358.3,28719,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28719,1,3,0)
 ;;=3^Factitious D/O Imposed on Another
 ;;^UTILITY(U,$J,358.3,28719,1,4,0)
 ;;=4^F68.A
 ;;^UTILITY(U,$J,358.3,28719,2)
 ;;=^5157309
 ;;^UTILITY(U,$J,358.3,28720,0)
 ;;=L98.1^^115^1415^5
 ;;^UTILITY(U,$J,358.3,28720,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28720,1,3,0)
 ;;=3^Factitial Dermatitis
 ;;^UTILITY(U,$J,358.3,28720,1,4,0)
 ;;=4^L98.1
 ;;^UTILITY(U,$J,358.3,28720,2)
 ;;=^186781
 ;;^UTILITY(U,$J,358.3,28721,0)
 ;;=N94.3^^115^1415^9
 ;;^UTILITY(U,$J,358.3,28721,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28721,1,3,0)
 ;;=3^Premenstrual Tension Syndrome
 ;;^UTILITY(U,$J,358.3,28721,1,4,0)
 ;;=4^N94.3
 ;;^UTILITY(U,$J,358.3,28721,2)
 ;;=^5015919
 ;;^UTILITY(U,$J,358.3,28722,0)
 ;;=F91.2^^115^1416^1
 ;;^UTILITY(U,$J,358.3,28722,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28722,1,3,0)
 ;;=3^Conduct D/O,Adolescent-Onset Type
 ;;^UTILITY(U,$J,358.3,28722,1,4,0)
 ;;=4^F91.2
 ;;^UTILITY(U,$J,358.3,28722,2)
 ;;=^5003699
 ;;^UTILITY(U,$J,358.3,28723,0)
 ;;=F91.1^^115^1416^2
 ;;^UTILITY(U,$J,358.3,28723,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28723,1,3,0)
 ;;=3^Conduct D/O,Childhood-Onset Type
 ;;^UTILITY(U,$J,358.3,28723,1,4,0)
 ;;=4^F91.1
 ;;^UTILITY(U,$J,358.3,28723,2)
 ;;=^5003698
 ;;^UTILITY(U,$J,358.3,28724,0)
 ;;=F91.9^^115^1416^3
 ;;^UTILITY(U,$J,358.3,28724,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28724,1,3,0)
 ;;=3^Conduct D/O,Unspec
 ;;^UTILITY(U,$J,358.3,28724,1,4,0)
 ;;=4^F91.9
 ;;^UTILITY(U,$J,358.3,28724,2)
 ;;=^5003701
 ;;^UTILITY(U,$J,358.3,28725,0)
 ;;=F63.81^^115^1416^6
 ;;^UTILITY(U,$J,358.3,28725,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28725,1,3,0)
 ;;=3^Intermittent Explosive D/O
 ;;^UTILITY(U,$J,358.3,28725,1,4,0)
 ;;=4^F63.81
 ;;^UTILITY(U,$J,358.3,28725,2)
 ;;=^5003644
 ;;^UTILITY(U,$J,358.3,28726,0)
 ;;=F63.2^^115^1416^7
 ;;^UTILITY(U,$J,358.3,28726,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28726,1,3,0)
 ;;=3^Kleptomania
 ;;^UTILITY(U,$J,358.3,28726,1,4,0)
 ;;=4^F63.2
 ;;^UTILITY(U,$J,358.3,28726,2)
 ;;=^5003642
 ;;^UTILITY(U,$J,358.3,28727,0)
 ;;=F91.3^^115^1416^8
 ;;^UTILITY(U,$J,358.3,28727,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28727,1,3,0)
 ;;=3^Oppositional Defiant D/O
 ;;^UTILITY(U,$J,358.3,28727,1,4,0)
 ;;=4^F91.3
 ;;^UTILITY(U,$J,358.3,28727,2)
 ;;=^331955
 ;;^UTILITY(U,$J,358.3,28728,0)
 ;;=F63.1^^115^1416^9
 ;;^UTILITY(U,$J,358.3,28728,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28728,1,3,0)
 ;;=3^Pyromania
 ;;^UTILITY(U,$J,358.3,28728,1,4,0)
 ;;=4^F63.1
 ;;^UTILITY(U,$J,358.3,28728,2)
 ;;=^5003641
 ;;^UTILITY(U,$J,358.3,28729,0)
 ;;=F91.8^^115^1416^4
 ;;^UTILITY(U,$J,358.3,28729,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28729,1,3,0)
 ;;=3^Disruptive,Impulse-Control & Conduct D/O,Oth 
 ;;^UTILITY(U,$J,358.3,28729,1,4,0)
 ;;=4^F91.8
 ;;^UTILITY(U,$J,358.3,28729,2)
 ;;=^5003700
 ;;^UTILITY(U,$J,358.3,28730,0)
 ;;=R45.6^^115^1416^10
 ;;^UTILITY(U,$J,358.3,28730,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28730,1,3,0)
 ;;=3^Violent Behavior
 ;;^UTILITY(U,$J,358.3,28730,1,4,0)
 ;;=4^R45.6
